On 07 May 2019
Glenmark Pharmaceuticals Ltd., a research‐led global integrated pharmaceutical company, today announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences Ltd, its subsidiary for the API (Active Pharmaceutical Ingredients) business.He has over 25 years of experience in the pharmaceutical industry. He has a Ph.D. in Chemistry from Texas A&M University, USA and holds a degree in B.Sc.(Tech.) from UDCT Mumbai, India.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
